Friday, November 16, 2012
Print Current Session:
|
|
Friday
SESSION 29:
ADVANCES IN MEDICAL THERAPY OR TREATMENT OF MEDICAL PROBLEMS OR COMPLICATIONS (5-MINUTE TALKS)
Moderators:Anton N. Sidawy, MD, MPH / Plinio Rossi, MD
|
|
SESSION 29 SCHEDULE | |
10:45 AM - 10:50 AM | Platelet Activity And Optimizing Antiplatelet Treatment: The Next Frontier In Vascular Disease Management |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
10:51 AM - 10:56 AM | What’s New With Endovascular Ablation Procedures For Atrial And Ventricular Arrhythmias |
Presenter(s):Larry Chinitz, MD | |
10:57 AM - 11:02 AM | Why Do Statins Decrease Preoperative And Periprocedural Risks: What Is Optimal Drug Dose And Timing |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
11:03 AM - 11:08 AM | What’s All This Hoopla About Statins And Mental Fogginess, Increased Blood Sugar And Diabetes: Should It Make A Difference In Statin Usage Or Is It A Witch Hunt |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
11:09 AM - 11:14 AM | New Concepts Regarding The Importance Of Plaque Instability And Stability In Coronary And Vascular Disease: How Instability Should Be Determined And Treated |
Presenter(s):Gregg W. Stone, MD | |
11:15 AM - 11:20 AM | High Incidence Of Asymptomatic Elevated Troponin Levels (Troponin-Only MIs) After Open Vascular Surgery: What Does It Mean And What Can Be Done To Decrease It |
Presenter(s):Caron B. Rockman, MD | |
11:21 AM - 11:26 AM | DEBATE: Why We Should Not Stop Screening For Asymptomatic Carotid Stenosis |
Presenter(s):Glenn Jacobowitz, MD | |
11:27 AM - 11:32 AM | DEBATE: We Should Stop Screening For Asymptomatic Carotid Stenosis Even Though There Is A Substantial Incidence Of Silent Cerebral Events In These Patients: What Should We Do About It |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:33 AM - 11:38 AM | What’s New About The Role Of Cilostazol In Patients With Vascular Disease: What Are Some Of Its Newly Found Benefits |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
11:39 AM - 11:44 AM | DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: Yes, It Decreases Risk And Is Cost Effective |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
11:45 AM - 11:50 AM | DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: No, It Is Too Dangerous; Better To Wait For Symptoms |
Presenter(s):Erich Minar, MD | |
11:51 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break (Americas Hall - 3rd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
previous | next |